-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS TO REQUEST FDA TYPE C MEETING TO DISCUSS OVERALL SURVIVAL DATA IN GBM AND POTENTIAL NDA FILING IN ALIGNMENT WITH FDA INITIATIVE PROJECT FRONTRUNNER

Reuters·10/27/2025 11:15:34

Please log in to view news